RIO DE JANEIRO, BRAZIL - "There are many doubts. It is increasingly clear that antivirals could be useful in the early stages. We don't know which one is effective, but they are probably of little use in advanced stages, when a host's excessive inflammatory response prevails".
Jesús Rodríguez Baño, head of the Infectious Disease Service at the Virgen de la Macarena University Hospital in Seville (Spain), summarizes in a message the situation faced by many doctors and researchers in the face of the novel coronavirus." At this time, in well-selected patients, immunosuppressive drugs seem to . . .